CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 52,629 shares at an average $14.23 ($748,697)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes SVP, Chief Technical Officer gave up 3,044 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 4,508 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 19,511 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Technical Officer gave up 1,995 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 2,700 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 14,244 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel gave up 1,681 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Technical Officer gave up 2,725 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 3,894 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 16,259 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes SVP, Chief Technical Officer gave up 4,289 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 8,275 shares (to pay taxes)
Page 15 of 39 · 775 filings